FAAM EUROBAT 2024
BackEBPS - EUROBAT POSTER SESSION
Thursday 21 Nov, 11:00 AM -
11:30 AM Athens, Greece
Ypsilon & Omikron
Poster Session
11:00
Day1-12
Automation of the Pooled Donor Basophil Activation Test for Chronic Urticaria using the Hamilton STAR: Enhancing Efficiency over the Manual Assay
11:00
Day1-08
BAT takes the lead: Cashew and Ana o 3 BAT outperform standard allergy testing
11:00
Day1-03
Basophil Activation Test: A useful functional tool for investigation of Human Serum Albumine anaphylaxis (Case report)
11:00
Day1-06
Basophil FceRI expression-A management tool in anti-IgE treatment of allergic asthma
11:00
Day1-09
Basophil activation test in chronic spontaneous urticaria: a longitudinal assessment
11:00
Day1-02
Comparison of basophil activation by different yellow jacket venoms from three continents and venom used in immunotherapy
11:00
Day1-13
Development of a Novel Protocol for Assessing Basophil and Neutrophil Activation in Response to Allergens
11:00
Day1-05
Impact of lysosomotropic agents on human primary mast cells isolated from nasal polyps
11:00
Day1-15
Molecular Standardisation and Validation of Allergens for Basophil and Mast Cell Activation Tests
11:00
Day1-07
Nanoparticles to improve safety and efficacy of allergen specific immunotherapy: comparison of mesoporous silica nanoparticles and cubosomes
11:00
Day1-01
Novel Applications for Basophil Activation Test: From Allergy to Oncology
11:00
Day1-14
Novel strategies for predicting allergenicity: development of a ranking method and screening of existing tools to assess the allergy risk of innovative proteins
11:00
Day1-04
Stochastic interpretation of basophil activation test improves diagnostic reliability
11:00
Day1-11
Use of Basophil Activation Test in Cephalosporin Allergy
11:00
Day1-10
Use of dendrimeric nanostructures in mast cell activation test for evaluating IgE-mediated hypersensitivity to amoxicillin
